摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate

中文名称
——
中文别名
——
英文名称
[(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate
英文别名
——
[(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate化学式
CAS
——
化学式
C17H23N4O9P
mdl
——
分子量
458.365
InChiKey
YTNIXZGTHTVJBW-MBNYWOFBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.3
  • 重原子数:
    31
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.41
  • 拓扑面积:
    201
  • 氢给体数:
    8
  • 氢受体数:
    11

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Enzymatic Single-Molecule Kinetic Isotope Effects
    作者:Christopher R. Pudney、Richard S. K. Lane、Alistair J. Fielding、Steven W. Magennis、Sam Hay、Nigel S. Scrutton
    DOI:10.1021/ja309286r
    日期:2013.3.13
    Ensemble-based measurements of kinetic isotope effects (KIEs) have advanced physical understanding of enzyme-catalyzed reactions, but controversies remain. KIEs are used as reporters of rate-limiting H-transfer steps, quantum mechanical tunnelling, dynamics and multiple reactive states. Single molecule (SM) enzymatic KIEs could provide new information on the physical basis of enzyme catalysis. Here, single pair fluorescence energy transfer (spFRET) was used to measure SM enzymatic KIEs on the H-transfer catalyzed by the enzyme pentaerythritol tetranitrate reductase. We evaluated a range of methods for extracting the SM ICE from single molecule spFRET time traces. The SM KIE enabled separation of contributions from nonenzymatic protein and fluorophore processes and H-transfer reactions. Our work demonstrates SM KIE analysis as a new method for deconvolving reaction chemistry from intrinsic dynamics.
  • Mechanism of the Reaction between Cyanocobalamin and Reduced Flavin Mononucleotide
    作者:I. A. Dereven’kov、K. A. Ugodin、S. V. Makarov
    DOI:10.1134/s003602442110006x
    日期:2021.10
    the kinetics of the reaction between cyanocobalamin (vitamin B12, CNCbl) and the reduced form of flavin mononucleotide (FMNH2) in weakly acidic, neutral, and slightly alkaline media is performed. It is shown that FMNH2 can reduce CNCbl to cobalamin(II) (Cbl(II)). It is established that protonated, mono-deprotonated, and di-deprotonated forms of FMNH2 can participate in the reaction. The reaction mechanism
    摘要 对氰钴胺素(维生素 B 12,CNCbl)与还原形式的黄素单核苷酸 (FMNH2) 在弱酸性、中性和弱碱性介质中的反应动力学进行了研究。结果表明,FMNH2 可以将 CNCbl 还原为钴胺素 (II) (Cbl(II))。已确定质子化、单去质子化和双去质子化形式的 FMNH2 可以参与反应。反应机制包括用 FMNH2 分子缓慢取代 5,6-二甲基苯并咪唑核苷酸,从 FMNH2 到 Co(III) 离子的快速电子转移,以及随后氰化物的解离。由于氧化形式的 FMNH2 (FMN) 能够与 Cbl(II) 络合物反应,因此该反应是可逆的。
查看更多

同类化合物

腺嘌呤黄素 核黄素磷酸钠 核黄素杂质B 核黄素5'-焦磷酸盐 核黄素4′,5′-二磷酸酯 [5-(6-氨基嘌呤-9-基)-4-羟基-3-膦酰氧基四氢呋喃-2-基]甲基[[5-(7,8-二甲基-2,4-二氧代苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[5-(7,8-二甲基-2,4-二氧代-6-硫氰酸基苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[5-(7,8-二甲基-2,4-二氧代-6-硫代-1H-苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 [5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[5-(6-叠氮基-7,8-二甲基-2,4-二氧代苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 [(2S,3R,4R)-5-(7,8-二甲基-2,4-二氧代苯并[g]蝶啶-10-基)-2,3,4-三羟基戊基]磷酸二氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[(2S,3R,4S)-5-(7,8-二甲基-2,4-二氧代苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 [(2R,3S,4R,5R)-5-(6-氨基嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基]甲基[[(2R,3S,4S)-5-(7,8-二甲基-2,4-二氧代-1,5-二氢苯并[g]蝶啶-10-基)-2,3,4-三羟基戊氧基]-羟基磷酰]磷酸氢酯 2,6-蒽二酚 1-脱氧-1-(7,8-二甲基-2,4-二氧代-1,3,4,5-四氢苯并[g]蝶啶-10(2H)-基)-5-O-膦酰戊糖醇 8-formyl-riboflavin-5′-phosphate riboflavin adenine dinucleotide riboflavin 5'-phosphate [[(2R,3S,4R,5R)-3,4-dihydroxy-5-(9H-imidazo[2,1-f]purin-6-ium-3-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] [(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate;chloride Riboflavin 5'-monophosphate sodium salt dihydrate Flavin adenine dinucleotide sodium salt 6-Hydroxy-fad Riboflavin 5a(2)-(trihydrogen diphosphate), 4a,5-dihydro-4a-hydroperoxy-, Pa(2)a5a(2)-ester with adenosine Lyxoflavin 5'-monophosphate Pharmakon1600-01505763 7,8-dimethyl-2,4-dioxo-10-[(2R,3S,4R)-2,3,4-trihydroxy-5-phosphonooxypentyl]benzo[g]pteridin-5-ium-5-sulfonic acid [(2R,3S,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate N(5)-sulfo-FADH2 [[(2R,3S,4R,5R)-5-(6-amino-4,5-dihydropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3S,4R,5S)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [(2S,3R,4R)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate [5-(8-Cyano-7-methyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate [(3S)-1-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-3-oxo-1,2,3lambda5-dioxaphosphiran-1-ium-3-yl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxo-1H-benzo[g]pteridin-10-ium-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [(2R,3S,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate [[(2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3R,4S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [(E)-3-[10-[(2S,3S,4R)-5-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2,3,4-trihydroxypentyl]-7,8-dimethyl-2,4-dioxo-1H-benzo[g]pteridin-5-yl]prop-2-enylidene]-benzyl-methylazanium [(2R,3R,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate [(2R,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] phosphate [(2R,3R,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen phosphate [[(2S,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R)-5-[7,8-dimethyl-5-(2-methylpropanoyl)-2,4-dioxobenzo[g]pteridin-5-ium-10-yl]-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S)-5-[7,8-dimethyl-5-[(E)-3-[methyl-[(2R)-1-phenylpropan-2-yl]amino]prop-1-enyl]-2,4-dioxo-1H-benzo[g]pteridin-10-yl]-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4S)-2,3,4-trihydroxy-5-[5-[3-[[(1R)-6-hydroxy-2,3-dihydro-1H-inden-1-yl]imino]propyl]-7,8-dimethyl-2,4-dioxo-1H-benzo[g]pteridin-10-yl]pentyl] hydrogen phosphate [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2S,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2S,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R)-5-(7,8-dimethyl-2,4,6-trioxo-1H-benzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [(2R,3S,4S)-2,3,4-trihydroxy-5-(11,12,14,14-tetramethyl-3,5-dioxo-1,4,6,8-tetrazatetracyclo[7.7.1.02,7.013,17]heptadeca-2(7),9(17),10,12,15-pentaen-8-yl)pentyl] dihydrogen phosphate [(2R,3S,4S)-5-[7,8-dimethyl-5-(3-methylbutyl)-2,4-dioxo-1H-benzo[g]pteridin-10-yl]-2,3,4-trihydroxypentyl] dihydrogen phosphate [[(2S,3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3R,4R)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate [[(2R,4S,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-[(2R,3S,4S)-5-(7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentoxy]-oxophosphanium